2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience.

Published in: Indian journal of cancer (2024)

Sunitinib should be given via the 2/1 schedule in Indian patients.

Keyphrases